Related Experiment Videos
Pre-death grief in Parkinson's caregivers: a pilot survey-based study
J H Carter1, K S Lyons, A Lindauer
1School of Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, USA. carterju@ohsu.edu
Parkinsonism & Related Disorders
|October 24, 2012
Summary
Pre-death grief affects 17% of Parkinson
Area of Science:
- Neurology
- Psychology
- Gerontology
Background:
- Prolonged grief is linked to adverse outcomes in dementia caregivers.
- Caregiver strain is recognized in Parkinson's disease (PD), but grief remains unexplored.
- Understanding PD caregiver grief may inform future interventions.
Purpose of the Study:
- Evaluate pre-death grief in Parkinson's disease (PD) caregivers.
- Compare non-motor (cognitive decline, depression, hallucinations) versus motor symptoms (mobility fluctuations) for associations with caregiver grief.
- Identify predictors of grief reactions in PD caregivers.
Main Methods:
- 74 volunteer caregivers completed the Marwit and Meuser Caregiver Grief Inventory (MM-CGI-SF).
- Caregivers reported on motor and non-motor symptoms of their PD relatives using UPDRS.
- T-tests and hierarchical regression analyzed grief subscales and symptom associations.
Main Results:
- 17% of caregivers reported significant pre-death grief.
- Higher grief scores correlated with more severe PD symptoms in relatives.
- Non-motor symptoms (14-23% variance) predicted more grief than motor symptoms (11-17% variance).
Conclusions:
- Pre-death grief is a significant issue for Parkinson's disease caregivers.
- Non-motor symptoms, particularly cognitive decline, are key predictors of caregiver grief.
- Both motor and non-motor symptoms contribute to caregiver grief severity.
Related Concept Videos
Bonanno's Theory of Grieving
Grieving is a complex psychological and emotional process that varies significantly among individuals. George Bonanno's research on bereavement identified four distinct patterns of grieving, offering a nuanced understanding of how people cope with significant loss, such as the death of a spouse, over extended periods. These patterns — resilience, recovery, chronic dysfunction, and delayed grief — highlight the diversity in emotional responses and adaptive mechanisms.
Resilience
The resilience...
Resilience
The resilience...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...